Skip to content
Search

Latest Stories

Jonathan Burton to receive RPS Charter Award for promoting the interests of pharmacy

Jonathan Burton will receive the 2022 RPS Charter Award for his outstanding work for the Society and the wider profession in promoting the interests of pharmacy.

The award will be presented by the President at a future meeting of Fellows and Members to take place at the Society’s Edinburgh office on 22nd March 2023.


Jonathan’s main role is as a practising, patient-facing pharmacist within the community in NHS Forth Valley where he uses his advanced practice skills and independent prescribing qualification to assess and treat acute ENT, dermatology, and respiratory conditions.

He was one of the first community pharmacist prescribers in Scotland and has always been at the forefront of innovation and service development.

Jonathan has demonstrated outstanding commitment and passion for the pharmacy profession throughout his career. He has excelled as a pharmacist in the Right Medicine Pharmacy group, on local and national committees, in advocacy for the pharmacy profession and as a local and national leader who is highly regarded as an exceptional role model for the profession.

His commitment to helping support and enhance the Royal Pharmaceutical Society (RPS) as a Scottish Pharmacy Board Member has been particularly significant: serving on the Board from 2012 – 2021 including time as Vice Chair and, from 2019 – 2021, Chair of the Board and Assembly Member.

Jonathan is an ambassador for the pharmacy profession, a true champion for community pharmacy and an exceptional leader. His practical, compassionate, and realistic nature and his ability to make everyone in the room feel valued and equal regardless of their skills, knowledge, or experience.

His outstanding contribution to pharmacy, patient care and his local community was recognised in 2018 when he was made a Member of the Order of the British Empire (MBE).

RPS President Professor Claire Anderson said: “Jonathan has had a significant impact on the practice of pharmacy. He has run an innovative pharmacy in Stirling for many years. He was one of the first community pharmacy prescribers. It was a pleasure to work with him when we were both board chairs and I am delighted to be able to present him with this prestigious award.”

Upon hearing of the Award, Jonathan Burton said: "I am absolutely delighted to receive the RPS Charter Award. For me, being a pharmacist and helping the public is a privilege. I've been very fortunate to have amazing support from family and colleagues throughout my career and I feel this recognition of my contribution belongs as much to them as it does to me.

“I'd like to pay particular tribute to the dedication and professionalism of all the pharmacy teams across Scotland, and those working in the various organisations that support them, who help deliver the Pharmacy First service to patients every day. It was a great experience to be involved in the early development of this service and it's a fantastic example of a shared vision for pharmacy becoming a reality. My involvement with RPS has always helped widen my professional perspective, supported my practice and I will always consider my membership, supporting other members and the wider profession to be a lifelong commitment."

Any Member or Fellow of the Society is eligible for nomination (with the exception of current Board and Assembly members who are ineligible whilst holding office). Nominations for the Charter Award can be made through the national Pharmacy Boards or Assembly members and are assessed by a panel consisting of the President, Treasurer and the three national Board Chairs.

More For You

Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less
Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less